In the press

Press releases & News

Lavie Bio Provides Product Pipeline Update for 2020

LAV211 bio-stimulant advancing towards anticipated 2022 commercial launch in spring wheat; Product advancement achieved in multiple programs   Rehovot, Israel – December 29, 2020 – Lavie Bio Ltd. (Lavie Bio), a leading ag-biologicals company focusing on improving food quality, sustainability and agriculture productivity through the introduction of microbiome-based products, and a subsidiary of Evogene Ltd.

Read more

Lavie Bio Announces the Appointment of Frederic C. Beudot, Global Portfolio Leader for Biologicals at Corteva Agriscience™, to its Board of Directors

Lavie Bio Announces the appointment of Frederic C. Beudot, Global Portfolio Leader for Biologicals at Corteva Agriscience™, as a member of  its Board of directors. With extensive experience in sales, marketing, commercial and strategy of crop protection product, Frederic will allow us to further strengthen our market and commercial focus as we progress toward product

Read more

Lavie Bio Announces Advancement in its Product Development Pipeline for Wheat Bio-Stimulants

Leading wheat bio-stimulant candidate for spring wheat, exhibiting consistent performance, advancing to ‘development stage 2’, in line with Lavie Bio’s commercialization plans for 2022 Rehovot, Israel – November 18, 2019 – Lavie Bio (Lavie), a subsidiary of Evogene (NASDAQ: EVGN, TASE: EVGN), aiming to improve food quality, sustainability and agriculture productivity through the introduction of

Read more